Dyne Therapeutics Inc. (DYN) at a glance

Dyne Therapeutics Inc. (DYN) is a mid-cap Healthcare company. It trades at $18.5, with a 0% profit margin. It does not pay a dividend. Vestovix scores it 47/100 overall. Its strongest dimension is Value (50/100) and its weakest is Income (40/100). Its volatility is roughly in line with the market.

Price

$18.50

Market cap

$3.01B

P/E ratio

n/a

Dividend yield

None

Beta

1.08

52-week range

$11.92 to $27.31